No image

Lumipulse B-Amyloid Plasma Controls

Lumipulse B-Amyloid Plasma Controls 2x2C, IVD-US

Details

Device typeAmyloid B component IVD, control: A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of amyloid B component in a clinical specimen.

FDA categoryImmunoassay Blood Test For Amyloid Pathology Assessment

Device ID05414470815593

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Size4 bottles per unit; 1.5 mL per bottle

Contact

Phone+32093291329

Emailinfo@fujirebio.com

Related products

Product	Model	Company	Device type
Lumipulse pTau 217 Plasma ControlsFujirebio EuropeTau protein IVD, control	81558	Fujirebio Europe	Tau protein IVD, control
Lumipulse B-Amyloid ControlsFujirebio Inc.Amyloid B component IVD, control	234907	Fujirebio Inc.	Amyloid B component IVD, control
Lumipulse G pTau 217 Plasma CalibratorsFujirebio EuropeTau protein IVD, calibrator	81557	Fujirebio Europe	Tau protein IVD, calibrator
Elecsys Beta-Amyloid (1-42) CSF IIRoche Diagnostics GmbHAmyloid B component IVD, kit, chemiluminescent immunoassay	08821909160	Roche Diagnostics GmbH	Amyloid B component IVD, kit, chemiluminescent immunoassay

Product	Model	Company	Device type